Stem cells prove effective in new diabetes treatment

May 2007
Pharmaceutical Representative;May2007, Vol. 37 Issue 5, p11
The article focuses on the study that investigates the effectiveness of stem-cell transplants in treating diabetes conducted by the Brazilian Ministry of Health in Brazil. The study involves patients age 14 to 31, all of them recently diagnosed with Type 1 diabetes. Richard Burt of Northwestern University's Medical school, the lead author of the study claims that patients are completely medication free off insulin after the stem cell treatment.


Related Articles

  • Stem Cell Transplant Shows Promise For Early Stage MS. Breindl, Anette // BioWorld Today;2/2/2009, Vol. 20 Issue 20, p1 

    The article discusses research on the transplantation of autologous stem cells into patients with early-stage multiple sclerosis (MS). According to the January 30, 2009 online edition of "Lancet Neurology," about 80% of patients improved neurologically by at least one point on the Expanded...

  • Stem-cell therapy for type 1 diabetes. Leavy, Olive // Nature Reviews Immunology;May2007, Vol. 7 Issue 5, p326 

    The article focuses on stem cell transfusion as a potential therapy for type 1 diabetics. Results from a clinical trial reveal that 11 out of the 15 patients subjected to stem cell transplantation became insulin dependent. These imply that people's immune system can be restrained and reset for...

  • Nature Genetics: A new approach to treating type I diabetes? Gut cells transformed into insulin factories.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article focuses on a new study led by Columbia researchers which suggests the use of patient's intestinal cells in making insulin for treatment against type I diabetes and use of this insulin as a replacement of stem cell replacement therapy.

  • Insulin-producing neurospheres.  // PLoS Medicine;Apr2005, Vol. 2 Issue 4, p269 

    Discusses research being done on the differentiation of insulin-producing cells from human neural progenitor cells. Reference to a study by Seung Kim and colleagues published in this issue; Availability of recombinant insulin; Search for renewable sources of insulin-producing cells through...

  • An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes. Snarski, Emilian; Szmurło, Daria; Hałaburda, Kazimierz; Król, Małgorzata; Urbanowska, Elżbieta; Milczarczyk, Alicja; Franek, Edward; Wiktor-Jedrzejczak, Wiesław // Acta Diabetologica;Oct2015, Vol. 52 Issue 5, p881 

    Aims: Autologous hematopoietic stem cell transplantation (AHSCT) is an emerging treatment option in new onset type 1 diabetes (T1DM), leading to a remission of the T1DM for a longer time period in up to 50 % of patients. The aim of the study was to analyze the cost-effectiveness of this...

  • Hope For a Type 1 Diabetes Cure?  // Diabetes Health;Jun/Jul2007, Vol. 16 Issue 3, p19 

    The article discusses research being done on the effectiveness of the procedure called autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) in treating type 1 diabetes. It references a study by researchers from Sao Paulo, Brazil, published in the April 2007 issue of the...

  • 'Major breakthrough' for diabetes cure. Turnbull, Alex // Independent Nurse;Oct2014, p23 

    No abstract available.

  • Stem cell safety. Swift, Jennifer // New Scientist;2/23/2008, Vol. 197 Issue 2644, p21 

    The article reports on the safety of stem cell research. It notes that induced pluripotent stem (iPS) cells produce tumours in the animals which have received the transplants. It cites that women must not be subjugated to the health risks of donating eggs for cloning therapy when iPS cells...

  • Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation. Herrera, Alex F.; Soriano, Gabriela; Bellizzi, Andrew M.; Hornick, Jason L.; Ho, Vincent T.; Cutler, Corey S.; Antin, Joseph H.; Soiffer, Robert J.; Marty, Francisco M.; Baden, Lindsey R.; Ballen, Karen K. // New England Journal of Medicine;9/1/2011, Vol. 365 Issue 9, p815 

    Background: Diarrhea is a frequent complication of hematopoietic stem-cell transplantation (HSCT). Important causes of diarrhea after HSCT include acute graft-versus-host disease (GVHD), infections, and medications. After the transplantation and engraftment of hematopoietic stem cells from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics